• Issue

    Hematological Oncology: Volume 35, Issue 2

    143-256
    June 2017
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 143-144
  • First Published: 16 June 2017

REVIEW

New strategies in myelofibrosis: the evolving paradigm of disease pathogenesis, prognostication and treatment

Francesca Palandri,  Giuseppe Auteri,  Michele Baccarani, 
  • Pages: 145-150
  • First Published: 10 August 2016

ORIGINAL RESEARCH ARTICLES

Impact on survival of addition of etoposide to primary chemotherapy in diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study

Tove Wästerlid,  Linda Hartman,  Elisabeth Székely,  Mats Jerkeman, 
  • Pages: 151-157
  • First Published: 15 September 2015

Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy

Miki Takahara,  Toshihiro Nagato,  Kan Kishibe,  Seigo Ueda,  Yuki Komabayashi,  Masaaki Yamashina,  Kouji Takahashi,  Yasuaki Harabuchi, 
  • Pages: 158-162
  • First Published: 13 November 2015

CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin

Yuhei Shibata,  Takeshi Hara,  Senji Kasahara,  Toshiki Yamada,  Michio Sawada,  Ryoko Mabuchi,  Takuro Matsumoto,  Nobuhiko Nakamura,  Hiroshi Nakamura,  Soranobu Ninomiya,  Junichi Kitagawa,  Nobuhiro Kanemura,  Yusuke Kito,  Naoe Goto,  Tatsuhiko Miyazaki,  Tsuyoshi Takami,  Tamotsu Takeuchi,  Masahito Shimizu,  Hisashi Tsurumi, 
  • Pages: 163-171
  • First Published: 09 October 2015

Human papillomavirus infection and lymphoma incidence using cervical conization as a surrogate marker: a Danish nationwide cohort study

Suthida Intaraphet,  Dóra Körmendiné Farkas,  Sigrun Alba Johannesdottir Schmidt,  Deirdre Cronin-Fenton,  Mette Søgaard, 
  • Pages: 172-176
  • First Published: 02 November 2015

Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma

Barbara Kiesewetter,  Werner Dolak,  Ingrid Simonitsch-Klupp,  Marius E. Mayerhoefer,  Markus Raderer, 
  • Pages: 177-186
  • First Published: 18 November 2015

Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling

Thomas Menter,  Michael Dickenmann,  Darius Juskevicius,  Juerg Steiger,  Stephan Dirnhofer,  Alexandar Tzankov, 
  • Pages: 187-197
  • First Published: 22 January 2016

Non-Hodgkin lymphoma in Romania: a single-centre experience

Bogdan Fetica,  Patriciu Achimas-Cadariu,  Bogdan Pop,  Delia Dima,  Ljubomir Petrov,  Anamarija M. Perry,  Bharat N. Nathwani,  Hans K. Müller-Hermelink,  Jacques Diebold,  Kenneth A. MacLennan,  Annamaria Fulop,  Mihaiela L. Blaga,  Daniela Coza,  Florian Al. Nicula,  Alexandru Irimie,  Dennis D. Weisenburger, 
  • Pages: 198-205
  • First Published: 20 October 2015

Associations between statin use and non-Hodgkin lymphoma (NHL) risk and survival: a meta-analysis

Xibiao Ye,  Ayat Mneina,  James B. Johnston,  Salaheddin M. Mahmud, 
  • Pages: 206-214
  • First Published: 20 October 2015

Clinical characteristics of chronic lymphocytic leukemia occurring in chornobyl cleanup workers

Stuart C. Finch,  Irina Dyagil,  Robert F. Reiss,  Nataliya Gudzenko,  Nataliya Babkina,  Tatiana Lyubarets,  Volodymyr Bebeshko,  Anatoly Romanenko,  Vadim V. Chumak,  Andre Bouville,  Maureen Hatch,  Mark P. Little,  Dimitry Bazyka,  Lydia B. Zablotska, 
  • Pages: 215-224
  • First Published: 25 January 2016

The importance of the number of transplanted cells with dipeptidyl peptidase-4 expression on the haematopoietic recovery and lymphocyte reconstitution in patients with multiple myeloma after autologous haematopoietic stem-cell transplantation

Anna Kopinska,  Małgorzata Krawczyk-Kulis,  Joanna Dziaczkowska-Suszek,  Katarzyna Bieszczad,  Krystyna Jagoda,  Slawomira Kyrcz-Krzemien, 
  • Pages: 225-231
  • First Published: 02 November 2015

Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a ‘real-life’ patient population with chronic myeloid leukaemia

Roberto Latagliata,  Ida Carmosino,  Federico Vozella,  Paola Volpicelli,  Federico De Angelis,  Maria Giovanna Loglisci,  Adriano Salaroli,  Maria Lucia De Luca,  Chiara Montagna,  Alessandra Serrao,  Matteo Molica,  Daniela Diverio,  Mauro Nanni,  Marco Mancini,  Massimo Breccia,  Giuliana Alimena, 
  • Pages: 232-236
  • First Published: 09 December 2015

Major impact of an early bone marrow checkpoint (day 21) for minimal residual disease in flow cytometry in childhood acute lymphoblastic leukemia

Marion Eveillard,  Nelly Robillard,  Isabelle Arnoux,  Richard Garand,  Fanny Rialland,  Caroline Thomas,  Marion Strullu,  Gérard Michel,  Marie C. Béné,  Chantal Fossat,  Marie Loosveld, 
  • Pages: 237-243
  • First Published: 09 October 2015

LETTER TO THE EDITOR

Limited efficacy of HLA-haploidentical peripheral blood stem cell infusion in treatment of elderly patients with acute myelogenous leukaemia

Zuzana Sustkova,  Ivana Jeziskova,  Dana Dvorakova,  Ondrej Horky,  Lukas Semerad,  Barbora Weinbergerova,  Martin Culen,  Jiri Mayer,  Zdenek Racil, 
  • Pages: 244-245
  • First Published: 27 August 2015

CASE REPORTS

Safety and tolerability of pomalidomide-based regimens (pomalidomide-carfilzomib-dexamethasone with or without cyclophosphamide) in relapsed/refractory multiple myeloma and severe renal dysfunction: a case series

Joshua Richter,  Noa Biran,  Narjust Duma,  David H. Vesole,  David Siegel, 
  • Pages: 246-251
  • First Published: 27 March 2016

Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia

Sarah Bétrian,  Sarah Guenounou,  Isabelle Luquet,  Cécile Demur,  Anne Huynh,  Loïc Ysebaert,  Christian Recher,  Françoise Huguet, 
  • Pages: 252-255
  • First Published: 08 October 2015

BOOK REVIEW

Lecture Notes: Oncology, 3rd Edition. Mark Bower and Jonathan Waxman. Wiley-Blackwell, 2016, Ebook/Paperback, 352 pp., Prices starting from 23.80 euros

Francesco Bertoni, 
  • Page: 256
  • First Published: 16 June 2017